Search research articles
Contact Us
Filters
Showing results (1-10 of 347) with videos related to
Page
of 35
Sort By:
Cancer Pathogenesis and Therapy
|
February 8, 2024
Landscape of the clinical development of China innovative anti-lung cancer drugs
Yuankai Shi
International Journal of Hematology
|
February 2, 2018
Current status and progress of lymphoma management in China
Yuankai Shi
Thoracic Cancer
|
September 22, 2020
Prognostic value of pretreatment smoking status for small cell lung cancer: A meta-analysis
Liling Huang, Yuankai Shi
Frontiers in Oncology
|
February 1, 2021
Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
Qiaofeng Zhong, Yuankai Shi
Thoracic Cancer
|
August 15, 2015
Medical management of lung cancer: Experience in China
Yuankai Shi, Yan Sun
Frontiers in Immunology
|
December 12, 2022
Immunogenomic correlates of immune-related adverse events for anti-programmed cell death 1 therapy
Lei Zhang, Yuankai Shi, Xiaohong Han
Journal of Hematology & Oncology
|
October 28, 2020
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020)
Liling Huang, Shiyu Jiang, Yuankai Shi
Future Oncology (London, England)
|
February 8, 2022
Prognostic significance of baseline neutrophil-lymphocyte ratio in patients with non-small-cell lung cancer: a pooled analysis of open phase III clinical trial data
Liling Huang, Shiyu Jiang, Yuankai Shi
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
October 12, 2013
[Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small cell lung cancer]
Puyuan Xing, Junling Li, Yuankai Shi
Zhonghua Yi Xue Za Zhi
|
April 16, 2002
[Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients]
Xiaohong Han, Yuankai Shi, Wei Zhang
Page
of 35
Search research articles
Search
Showing results (1-10 of 347) with videos related to
Sort By:
Page
of 35
Cancer Pathogenesis and Therapy
|
February 8, 2024
Landscape of the clinical development of China innovative anti-lung cancer drugs
Yuankai Shi
International Journal of Hematology
|
February 2, 2018
Current status and progress of lymphoma management in China
Yuankai Shi
Thoracic Cancer
|
September 22, 2020
Prognostic value of pretreatment smoking status for small cell lung cancer: A meta-analysis
Liling Huang, Yuankai Shi
Frontiers in Oncology
|
February 1, 2021
Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
Qiaofeng Zhong, Yuankai Shi
Thoracic Cancer
|
August 15, 2015
Medical management of lung cancer: Experience in China
Yuankai Shi, Yan Sun
Frontiers in Immunology
|
December 12, 2022
Immunogenomic correlates of immune-related adverse events for anti-programmed cell death 1 therapy
Lei Zhang, Yuankai Shi, Xiaohong Han
Journal of Hematology & Oncology
|
October 28, 2020
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020)
Liling Huang, Shiyu Jiang, Yuankai Shi
Future Oncology (London, England)
|
February 8, 2022
Prognostic significance of baseline neutrophil-lymphocyte ratio in patients with non-small-cell lung cancer: a pooled analysis of open phase III clinical trial data
Liling Huang, Shiyu Jiang, Yuankai Shi
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
October 12, 2013
[Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small cell lung cancer]
Puyuan Xing, Junling Li, Yuankai Shi
Zhonghua Yi Xue Za Zhi
|
April 16, 2002
[Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients]
Xiaohong Han, Yuankai Shi, Wei Zhang
Page
of 35